{
  "DRAMP ID": "DRAMP01414",
  "Sequence": "GIFSTVFKAGKGIVCGLTGLC",
  "scores": {
    "mic": 6.0,
    "hemolysis": 7.0,
    "cytotoxicity": 8.0,
    "boman_score": 3.0,
    "protease": 5.0,
    "ph_thermal": 5.0,
    "half_life": 10,
    "length": 10.0,
    "rare_aa": 10.0,
    "disulfide": 8.0
  },
  "weighted_scores": {
    "efficacy": 2.16,
    "toxicity": 1.525,
    "stability": 1.3,
    "synthesis": 1.38
  },
  "total": 6.365,
  "APD3": {
    "sequence": "GIFSTVFKAGKGIVCGLTGLC",
    "length": 21,
    "hydrophobic_ratio": 52.0,
    "net_charge": 2,
    "molecular_weight": null,
    "gravy_value": null,
    "disulfide_bonds": 1,
    "detailed_info_fetched": true,
    "from_local_apd3": true,
    "apd_id": "AP01710",
    "detail_info": {
      "name_class": "Nigrocin-2ISa  (natural AMPs; frog, amphibians, animals; XXU; 1S=S, UCSS1a)",
      "source": "skin, the endangered frog, Odorrana ishikawae, Japan, Asia",
      "sequence": "GIFSTVFKAGKGIVCGLTGLC",
      "activity": "Anti-Gram+ & Gram-, Antifungal, candidacidal, Anti-MRSA",
      "crucial_residues": "",
      "additional_info": "Activity:  Active against E. coli (MIC 25 uM), S. aureus (MIC 3.1 uM), MRSA (MIC 12.5 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 50 uM).Updated 6/2023",
      "reference": "Peptides. 2011 Apr;32(4):670-6.Pub-Med.",
      "boman_index": -1.1,
      "length": 21,
      "net_charge": 2,
      "hydrophobic_ratio": 52.0,
      "disulfide_bonds": 1,
      "is_two_chain": false,
      "has_synergy": false
    },
    "boman_index": -1.1
  },
  "target_organisms": {
    "Gram-negative bacterium": [
      {
        "name": "Staphylococcus aureus",
        "activity": "MIC: 12.5 μg/ml"
      },
      {
        "name": "Bacillus subtilis",
        "activity": "MIC: 12.5 μg/ml"
      },
      {
        "name": "Escherichia coli",
        "activity": "MIC: 25 μg/ml"
      }
    ]
  }
}